• Serena Williams says GLP-1 treatment lowered her cholesterol and blood sugar and cut her risk of heart disease.
  • The tennis star appears in a Ro telehealth ad set to run during Super Bowl LX.
  • Williams began GLP-1 therapy about a year ago and credits it with improved health markers.

H2: Serena Williams highlights health gains in Super Bowl spot

Serena Williams is fronting a new Super Bowl ad for telehealth company Ro in which she credits GLP-1 medication with major health improvements. In the campaign, set to air during Super Bowl LX, Williams says that after about a year on the drug she has lower cholesterol and blood sugar than when she played professionally.

H3: Doctors say risk of heart disease has fallen

Williams told Ro that her doctors informed her the changes have “drastically” reduced her risk of developing heart disease. The ad positions those results alongside the convenience of Ro’s telehealth service, which connects patients with doctors and prescription options online.

H3: What the ad emphasizes

The spot focuses on measurable health markers rather than weight loss alone. Williams, a global sports icon, frames her experience around improved lab results — specifically cholesterol and blood sugar levels — and the medical reassurance she received from clinicians. Ro’s campaign uses her testimony to spotlight GLP-1 drugs as part of broader conversations about metabolic health.

H2: Context — GLP-1 drugs in the spotlight

GLP-1 medications, developed originally for diabetes and now widely used for weight management, have become central to public discussion and commercial campaigns. The class of drugs has attracted attention for both medical benefits and high demand. Ro’s ad taps that interest by pairing a high-profile endorsement with claims about clinical markers and reduced cardiovascular risk.

H3: Celebrity endorsements and public attention

Williams’ involvement follows several public figures sharing their experiences with GLP-1 treatments. Telehealth companies and pharmaceutical makers have increased advertising and outreach as consumers and clinicians weigh benefits, costs, and access. By running during the Super Bowl — one of the most-watched ad events in the U.S. — Ro aims to amplify those messages to a mass audience.

H2: What Williams says and what to watch for

Williams says she feels “healthier than ever” after a year on GLP-1 therapy. The ad highlights her clinical results and the medical advice she received, rather than offering medical guidance for viewers. Consumers interested in GLP-1 drugs should consult licensed clinicians to discuss suitability, risks and coverage options.

H3: Takeaway

The Ro Super Bowl spot uses Serena Williams’ high-profile story to humanize medical outcomes tied to GLP-1 drugs. It underscores how celebrity endorsements can shift public attention toward specific treatments and telehealth services, while reminding viewers that individual medical decisions should be made with a healthcare provider.

Image Referance: https://www.bloomberg.com/news/articles/2026-01-28/serena-williams-touts-glp-1-health-benefits-in-ro-super-bowl-ad